OCEANIA HEALTHCARE LIMITED (OCA)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

OCA

OCA - OCEANIA HEALTHCARE LIMITED

FNArena Sector : Aged Care & Seniors
Year End: March
GICS Industry Group : Health Care Equipment & Services
Debt/EBITDA: 209.43
Index:

LAST PRICE CHANGE +/- CHANGE % VOLUME

$0.76

05 Dec
2025

0.005

OPEN

$0.76

0.66%

HIGH

$0.76

2,634

LOW

$0.76

OTHER COMPANIES IN THE SAME SECTOR
EGH . INA . LIC . REG .
FNARENA'S MARKET CONSENSUS FORECASTS
OCA: 1
Title FY24
Actual		 FY25
Actual		 FY26
Forecast		 FY27
Forecast
EPS (cps) xxx 3.8 7.2 xxx
DPS (cps) xxx N/A 0.0 xxx
EPS Growth xxx N/A 89.5% xxx
DPS Growth xxx N/A N/A xxx
PE Ratio xxx N/A 10.5 xxx
Dividend Yield xxx N/A 0.0% xxx
Div Pay Ratio(%) xxx N/A N/A xxx

Dividend yield today if purchased 3 years ago: N/A

DIVIDEND YIELD CALCULATOR

Dividend Yield Today On Last Actual Payout :

 N/A

Estimated Dividend Growth
(Average Of Past Three Years)

Amount Invested

 $ 

Tell Me The Dividend After This Many Years
Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages

Last ex-div: 09/08 - (franking ex-di

HISTORICAL DATA ARE ALL IN AUD
Copyright © 2025 FactSet UK Limited. All rights reserved
Title 202020212022202320242025
EPS Basic xxxxxxxxxxxxxxx3.8
DPS All xxxxxxxxxxxxxxx0.0
Sales/Revenue xxxxxxxxxxxxxxx237.2 M
Book Value Per Share xxxxxxxxxxxxxxx138.3
Net Operating Cash Flow xxxxxxxxxxxxxxx83.6 M
Net Profit Margin xxxxxxxxxxxxxxx11.67 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 202020212022202320242025
Return on Capital Employed xxxxxxxxxxxxxxx2.85 %
Return on Invested Capital xxxxxxxxxxxxxxx1.78 %
Return on Assets xxxxxxxxxxxxxxx1.06 %
Return on Equity xxxxxxxxxxxxxxx2.85 %
Return on Total Capital xxxxxxxxxxxxxxx-1.11 %
Free Cash Flow ex dividends xxxxxxxxxxxxxxx47.0 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title 202020212022202320242025
Short-Term Debt xxxxxxxxxxxxxxx2 M
Long Term Debt xxxxxxxxxxxxxxx578 M
Total Debt xxxxxxxxxxxxxxx580 M
Goodwill - Gross xxxxxxxxxxxxxxx189 M
Cash & Equivalents - Generic xxxxxxxxxxxxxxx7 M
Price To Book Value xxxxxxxxxxxxxxx0.40

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title 202020212022202320242025
Capex xxxxxxxxxxxxxxx36.6 M
Capex % of Sales xxxxxxxxxxxxxxx15.44 %
Cost of Goods Sold xxxxxxxxxxxxxxx200 M
Selling, General & Admin. Exp & Other xxxxxxxxxxxxxxx55 M
Research & Development xxxxxxxxxxxxxxx-
Investments - Total xxxxxxxxxxxxxxx1,792 M

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

1.0

No. Of Recommendations

1
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Macquarie

24/11/2025

1

Outperform

-

-

Oceania Healthcare's interim result (March year-end) showed like-for-like earnings (EBITDA) up 23% as cost-out and improved Care execution lifted margins, explains Macquarie. Strong applications point to a solid 2H26 settlement profile.

Applications remain robust, the analyst notes, supporting a solid lift in 2H settlement volumes, which should help clear stock and strengthen free cash flow and debt reduction.

Total sales rose 5% y/y, with resales strong and new-sale timing issues expected to unwind, while village occupancy improved to 83.7%, highlights the broker.

Care earnings continued their step-change, with EBITDA per bed at a post-FY19 high and further upside to come, in Macquarie's view.
Outperform. Target price rises to NZ$1.04 from NZ$0.99.

FORECAST
Macquarie forecasts a full year FY26 dividend of 0.00 cents and EPS of 7.24 cents.
Macquarie forecasts a full year FY27 dividend of 1.36 cents and EPS of 8.78 cents.
Access Stockbroker Research History >
EXTRA COVERAGE
Display All Commentary

No. Of Recommendations

1

Please note: unlike Broker Call Report, BC Extra is not updated daily. The info you see might not be the latest. FNArena does its best to update ASAP.

BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Jarden

21/11/2025

3

Neutral

-

-

Jarden is encouraged by early signs at Oceania Healthcare of an earnings recovery, following a material deterioration in FY24 and FY25. Sales performance and cash conversion "looks encouraging".

On development, the broker envisages a shorter path to inventory sell down over FY26 and FY27. Forecasts highlight a steady path to improved profitability that should support a return to dividends in the next few years, depending on the approach the company takes to growth.

A Neutral rating is maintained but Jarden emphasises there is upside if the company can provide confidence on development. Target rises to NZ$0.84 from NZ$0.72.

FORECAST
Jarden forecasts a full year FY26 dividend of 0.00 cents and EPS of minus -0.63 cents.
Jarden forecasts a full year FY27 dividend of 0.00 cents and EPS of minus -2.17 cents.
Access Extra Coverage Research History >

OCA STOCK CHART

FNArena News on OCA

Latest Aged Care & Seniors News

1
Lifestyle Communities Enjoying Strong Demand

Feb 21 2022 - Small Caps
2
Aged Care Sector: Poised

Mar 16 2021 - Australia
3
Pressure Grows On Estia Health

Dec 10 2019 - Australia
4
Aveo Group Now A Binary Proposition

Jun 26 2019 - Australia
5
Aged Care Moves Into The RC Spotlight

Sep 20 2018 - Australia
6
Regis Healthcare In Strong Shape For FY19

Sep 04 2018 - Australia
7
Gateway Pays Up For Expansion

Mar 20 2018 - Small Caps
8
Challenging FY18 For Japara Healthcare

Dec 20 2017 - Small Caps
9
Estia Health Beset By Uncertainty

Dec 13 2016 - Australia
10
More Certainty Welcomed For Aged Care

Dec 07 2016 - Australia